Liu et al. indicated that overexpression of HLA-E in circulating tumor cells (CTC) engaged CD94-NKG2A inhibitory receptors on NK cells, blunting antitumor responses (Liu et al., 2023). This evidence concerns the gene KLRC1 and neoplasm.